We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

RNTX

1.96000 USD
0.16
8.89%
Last update May 13, 3:08 PM EDT
Market closed
Day range
1.70000
1.97000
Previous close
1.80000
Open
1.79000
Access this stock data via API
Subscribe
Rein Therapeutics Inc.
1.96
0.16
8.89%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 14.2M 4.0M 18.0M 17.0M
Selling general and admin 13.9M 11.4M 9.7M 9.6M
Other operating expenses
Operating income -28.1M -15.3M -27.6M -26.6M
Non operating interest income
Income 400K 400K 300K
Expense
Other income expense -36.6M -728K 318K 441K
Pretax income -64.3M -15.7M -27.3M -26.2M
Tax provision -1.5M
Net income -62.8M -15.7M -27.3M -26.2M
Basic EPS -3.5 -3.4 -6.0 -5.9
Diluted EPS -3.5 -3.4 -6.0 -5.9
Basic average shares 17.9M 4.6M 4.5M 4.4M
Diluted average shares 17.9M 4.6M 4.5M 4.4M
EBITDA 8.7M -14.5M -27.5M -26.5M
Net income from continuing op. -62.9M -15.7M -27.3M -26.2M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 5 minutes

03:54
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).